FDA Unveils Draft Proposals on Agency Disclosure Policies for Public Comment

Today, as part of the second phase of the Transparency Initiative, the Transparency Task Force released 21 draft proposals about FDA’s disclosure policies.  FDA is asking for comments on the proposals for 60 days.  After 60 days, FDA will use your input to recommend specific proposals to FDA Commissioner Dr. Margaret Hamburg for implementation. 

You can read more about the transparency report FDA is releasing today in a Perspective article in the New England Journal of Medicine online, “Transparency at the U.S. Food and Drug Administration.”

FDA will not necessarily implement each of these ideas.  Some of the proposals require extensive resources to implement and some may require changes to regulations or legislation. 

You can learn about the various ways to give us feedback here. 

Visit the FDA Web site to read the report and comment on the proposals.  You can let us know what you think about the proposals and what proposals FDA should prioritize, until July 20, 2010.

Afia Asamoah, Transparency Initiative Coordinator

Comments

[PG]

How and where do members of the public submit comments on the disclosure proposals?

[Afia Asamoah, Transparency Initiative Coordinator]

The FDA web site, www.fda.gov/transparencyreport, has been updated to make it easier to comment on the draft proposals. You can also learn about the other ways to give feedback to the task force at this website, https://www.fda.gov/AboutFDA/WhatWeDo/FDATransparencyTaskForce/ucm212908.htm

[Jim Tozzi]

Please visit the Interactive Public Docket on the FDA Tobacco Advisory Committee to see actions by non-federal groups to improve the transparency of FDA activities.

https://www.thecre.com/tpsac/